CREO
NEUTRALCreo Medical Group Announces Holding Change
The healthcare company has announced a change in its major shareholding, with M&G Plc increasing its stake to over 12%.
Creo Medical Group
12.25GBX
2.08%
Market Cap
50.53M
Volume
2.5k
1% of avg
P/E Ratio
-4.15
EPS (TTM)
-2.95
Beta
0.56
Day Range
0.00p - 0.00p
52 Week Range
0.00p12.25p37.00p
12.25p
Upcoming Events
CREO
NEUTRALCreo Medical Announces Interim Results Presentation
The medical device company will announce its interim results and host an online investor presentation.
CREO
NEUTRALCreo Medical Group CFO Transfers Shares to Children
The medical device company's CFO has transferred a portion of his shareholding to his children.
CREO
NEUTRALCreo Medical highlights successful Speedboat® procedure for patient
The medical device company shares a patient testimonial highlighting the benefits of its Speedboat® technology, which helped a patient avoid major surgery.
CREO
NEUTRALCreo Medical Group Awards Shares Under SIP, Directors Increase Stake
The medical device company has awarded shares to employees and directors under its Share Incentive Plan.
CREO
GOODCreo Medical Reports 40% Core Technology Revenue Growth in H1'25
The medical device company reports 40% growth in core technology revenues in the first half of 2025, in line with expectations, and is tracking on plan for full-year guidance.
CREO
NEUTRALCreo Medical Begins Landmark Lung Tumour Clinical Study for MicroBlate™ Flex
The medical device company has commenced a new clinical study evaluating the safety and performance of its MicroBlate™ Flex device for treating lung tumours.
CREO
NEUTRALCreo Medical Group Announces PDMR Options Revision
The medical device company has revised the exercise price of options granted to certain PDMRs.
CREO
NEUTRALCreo Medical Appoints Deutsche Bank as New Nominated Adviser
The medical device company has appointed Deutsche Bank AG, London Branch as its new Nominated Adviser and Broker, replacing Numis Securities Limited.
CREO
NEUTRALCreo Medical Provides AGM Update, Announces Board Changes
The medical device company provides an update ahead of its AGM, announcing board changes and highlighting progress in its core technology and product pipeline.